Medication Adherence: Clinical Trials

31 trials for Medication Adherence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 9 unknown, 2 terminated, 1 active not recruiting. 31 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 431Completed 16, Unknown 9, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Medication Adherence: new trials by email Literature Review of Medication Adherence trials Research Report on Medication Adherence

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer
Adherence package consisting of additional education and adherence reminders - Breast Cancer, Adherence, Medication
Phase 4Not yet recruitingInstitute of Oncology Ljubljana902026-09-012026-06-05
Oxymetazoline Bridge Therapy With Intranasal Corticosteroids in Pediatric Allergic Rhinitis
Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg, Oxymetazoline 0.05% nasal solution - Persistent Allergic Rhinitis
Phase 4CompletedDr. Behcet Uz Children's Hospital762025-01-022026-05-18
Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients
Terazosin - Parkinson Disease, Gait Analysis
Phase 4UnknownI.R.C.C.S. Fondazione Santa Lucia502023-12-012023-09-22
Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker
Piracetam - Drug Adherence Marker
Phase 4UnknownThe Netherlands Cancer Institute102023-07-032023-06-26
Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
Naltrexone-Bupropion Combination - Obesity, Morbid, Bariatric Surgery Candidate
Phase 4UnknownZuyderland Medisch Centrum1162023-03-212023-05-30
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Dropless Regimen, Standard Regimen - Cataract, Surgery
Phase 4RecruitingUniversity of California, San Francisco702022-05-312026-10-27
Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
Nocardia rubra Cell Wall Skeleton, Silver ions dressing - Diabetic Foot Ulcer, Therapy, Directly Observed
Phase 4UnknownThe Affiliated Hospital of Xuzhou Medical University1162022-05-202022-05-10
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
Low-dose aspirin - Medication Adherence, Preeclampsia
Phase 4WithdrawnWomen and Infants Hospital of Rhode Island2021-03-032025-04-04
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
Apixaban 2.5 milligram - Neoplasms Malignant, Surgery
Phase 4CompletedMcMaster University532021-02-222022-04-22
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
Elexacaftor/Tezacaftor/Ivacaftor - Cystic Fibrosis, Cystic Fibrosis Liver Disease
Phase 4Active not recruitingRoyal College of Surgeons, Ireland2062020-09-032026-09-09
DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior
Phase 4CompletedPublic Health Foundation Enterprises, Inc.1002019-02-012025-07-03
Balanced Placebo Design With Varenicline: Pharmacological and Expectancy Effects on Medication Adherence
Varenicline, Placebo - Medication Adherence
Phase 4CompletedUniversity of Alabama at Birmingham802018-11-062020-12-14
A Trial of Directly Observed and Long-term Varenicline
Long-Term Varenicline, Short-Term Varenicline, Directly Observed Therapy - Tobacco Use Disorder, Opioid-use Disorder
Phase 4CompletedAlbert Einstein College of Medicine2432018-10-252024-08-30
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
Digital pill, Truvada - HIV/AIDS, Substance Use Disorders
Phase 4CompletedBrigham and Women's Hospital162018-10-012022-12-22
CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
Abilify Maintena, Customized Adherence Enhancement (CAE) - Bipolar Disorder, Medication Adherence
Phase 4CompletedMartha Sajatovic302018-04-012022-02-17
DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence
Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior
Phase 4CompletedPublic Health Foundation Enterprises, Inc.202018-02-282021-10-27
Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Health education program, Conventional management - Chronic Obstructive Pulmonary Disease
Phase 4UnknownHospital Universitario La Paz1282016-10-012023-03-03
Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy
Digital Health Feedback System - HIV
Phase 4UnknownUniversity of California, San Diego1002016-06-012022-12-23
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
Aripiprazole Once-Monthly, Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc) - Schizophrenia
Phase 4UnknownMatt Byerly2002014-12-012015-06-08
Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin
TasP using ART regimen as per Benin guidelines, PrEP using Truvada - Adherence to Medication Regime
Phase 4CompletedCHU de Quebec-Universite Laval3612014-10-012017-07-19

Showing 20 of 31. Sign in to see all of them.

Narrower conditions

Health Education (4)  ·  Bipolar Disorder (3)  ·  Directly Observed Therapy (3)  ·  Patient Compliance (2)  ·  Risk-Taking (2)  ·  Schizophrenia (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Atrial Fibrillation (1)  ·  Breast Neoplasms (1)  ·  Cataract (1)  ·  Communicable Diseases (1)  ·  Cystic Fibrosis (1)  ·  Depression (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Behavior (31)  ·  Patient Acceptance of Health Care (31)  ·  Treatment Adherence and Compliance (31)  ·  Health Behavior (30)  ·  Patient Compliance (29)  ·  Mental Disorders (5)  ·  Adherence Interventions (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Bipolar and Related Disorders (3)  ·  Cardiovascular Diseases (3)  ·  Infections (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathologic Processes (3)  ·  Respiratory Tract Diseases (3)

Interventions

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (3)  ·  Tacrolimus (2)  ·  Varenicline (2)  ·  ziprasidone (2)  ·  Antipsychotic Agents (1)  ·  Aripiprazole (1)  ·  Aspirin (1)  ·  Control Groups (1)  ·  Educational Status (1)  ·  Emtricitabine (1)  ·  Hand Disinfection (1)  ·  Lisosan G (1)  ·  Lurasidone Hydrochloride (1)  ·  Metered Dose Inhalers (1)  ·  Mometasone Furoate (1)

Sponsors

Public Health Foundation Enterprises, Inc. (2)  ·  Albert Einstein College of Medicine (1)  ·  Brigham and Women's Hospital (1)  ·  CHU de Quebec-Universite Laval (1)  ·  Centers for Disease Control and Prevention (1)  ·  Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal (1)  ·  Consorci Hospitalari de Vic (1)  ·  Creighton University (1)  ·  Dr. Behcet Uz Children's Hospital (1)  ·  Fenway Community Health (1)  ·  GlaxoSmithKline (1)  ·  Hospital Universitario La Paz (1)  ·  I.R.C.C.S. Fondazione Santa Lucia (1)  ·  Institute of Oncology Ljubljana (1)  ·  Johns Hopkins University (1)

Countries

United States (15)  ·  Canada (2)  ·  Spain (2)  ·  Argentina (1)  ·  Benin (1)  ·  China (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Slovenia (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Susan Buchbinder, MD (2)  ·  Alwin Huitema, Prof. Dr. (1)  ·  Anna B Bowen, MD, MPH (1)  ·  Antonella Peppe, MD, PhD (1)  ·  Cara Tannenbaum, MD, MSc (1)  ·  Chin-Yuan Lee (1)  ·  Constance A Benson, MD (1)  ·  Dan Hilleman, PharmD (1)  ·  Francisco Garcia-Rio, MD (1)  ·  Jan Willem Greve, MD, PhD, professor (1)  ·  Kenneth Mayer, MD (1)  ·  Martha Sajatovic, M.D. (1)  ·  Martha Sajatovic, MD (1)  ·  Matt Byerly, MD (1)

Results publications

PMID 36094829, PMID 22992296, PMID 24711050, PMID 26058676, PMID 26551178, PMID 30056389, PMID 30422193, PMID 30870274, PMID 31303479, PMID 31452902, PMID 32114852, PMID 33044687, PMID 33105397, PMID 34534421, PMID 34753871, PMID 35089449, PMID 35362102, PMID 37703083, PMID 39222964, PMID 42843159

NIH funding

R01MH109320 (2), 1RC1CA144382-01 (1), R01DA042813 (1), R01MH110057 (1)